These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 2820313

  • 1. [MEP therapy of advanced lung cancer].
    Komuro Y, Ohnishi M, Saitoh A, Morohashi Y.
    Gan To Kagaku Ryoho; 1987 Sep; 14(9):2688-91. PubMed ID: 2820313
    [Abstract] [Full Text] [Related]

  • 2. [Clinical study of combination chemotherapy with mitomycin C, vindesine and cisplatin (MVP therapy) in advanced non-small cell lung cancer].
    Setoguchi J, Sawada M, Onodera H, Sigeta M, Nakai M, Nakano K, Kanatsuna T, Kondoh M, Hotta T, Hayashi H.
    Gan To Kagaku Ryoho; 1989 Jul; 16(7):2399-403. PubMed ID: 2546504
    [Abstract] [Full Text] [Related]

  • 3. [A randomized trial comparing vindesine plus cisplatin with mitomycin C, vindesine plus cisplatin in patients with advanced non-small cell lung cancer].
    Fujii M, Kiura K, Okabe K, Toki H, Kimura M.
    Gan To Kagaku Ryoho; 1987 Sep; 14(9):2676-81. PubMed ID: 2820312
    [Abstract] [Full Text] [Related]

  • 4. [Benefits of cisplatin-based polychemotherapy in non-small cell bronchogenic carcinoma. Kyushu Lung Cancer Chemotherapy Study Group].
    Ohta M, Hara N, Ichikawa Y, Kanda T, Shima K, Tamura K, Hokama M.
    Gan To Kagaku Ryoho; 1988 Jun; 15(6):1901-8. PubMed ID: 2454615
    [Abstract] [Full Text] [Related]

  • 5. Mitomycin C, vinblastine, and carboplatin regimen in patients with nonsmall cell lung cancer. A phase II trial.
    Paccagnella A, Favaretto A, Oniga F, Festi G, Lauro S, Morabito A, Ossana L, Sartore F, DePoli F, Fiorentino MV.
    Cancer; 1996 Oct 15; 78(8):1701-7. PubMed ID: 8859183
    [Abstract] [Full Text] [Related]

  • 6. Mitomycin, ifosfamide and cisplatin in advanced non-small cell lung cancer.
    Soh LT, Tan EH, Ang PT.
    Singapore Med J; 1998 Aug 15; 39(8):357-8. PubMed ID: 9844496
    [Abstract] [Full Text] [Related]

  • 7. The role of chemotherapy in non-small cell lung cancer: the community perspective.
    Folman RS, Rosman M.
    Semin Oncol; 1988 Jun 15; 15(3 Suppl 4):16-21. PubMed ID: 2839903
    [Abstract] [Full Text] [Related]

  • 8. Combination chemotherapy with ifosfamide, mitomycin, and cisplatin in advanced non-small cell lung cancer.
    Girón CG, Ordónez A, Jalón JI, Barón MG.
    Cancer Treat Rep; 1987 Sep 15; 71(9):851-3. PubMed ID: 3040245
    [Abstract] [Full Text] [Related]

  • 9. Cisplatin, vindesine, mitomycin-C and 13-cis retinoic acid in the treatment of advanced non small cell lung cancer. A phase II pilot study.
    Recchia F, Sica G, De Filippis S, Rosselli M, Saggio G, Guerriero G, Pompili P, Rea S.
    Anticancer Res; 2000 Sep 15; 20(3B):1985-90. PubMed ID: 10928138
    [Abstract] [Full Text] [Related]

  • 10. [Combination chemotherapy with etoposide, mitomycin C, and cyclophosphamide in advanced non-small cell lung cancer].
    Homma T, Yoneda S, Fukuda Y, Nakata M, Noguchi Y, Yoshida S.
    Gan To Kagaku Ryoho; 1986 Jul 15; 13(7):2399-403. PubMed ID: 3015045
    [Abstract] [Full Text] [Related]

  • 11. Treatment of advanced non-small cell lung cancer (NSCLC): the "Umbria" cooperative study.
    Crinó L, Darwish S, Corgna E, Meacci ML, Di Costanzo F, Buzzi F, Fornari G, Santi F, Ballatori E, Luccioli L.
    Semin Oncol; 1988 Dec 15; 15(6 Suppl 7):52-5. PubMed ID: 2851180
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Do the time to chemotherapy response and the dose intensity have an impact on patient outcome in advanced non-small cell lung cancer?
    Radosavljevic D, Golubicic I, Gavrilovic D, Kezic I, Jelic S.
    J BUON; 2009 Dec 15; 14(2):203-9. PubMed ID: 19650167
    [Abstract] [Full Text] [Related]

  • 14. [Combination chemotherapy with mitomycin C, adriamycin and cisplatin (MAP) in advanced adenocarcinoma of the lung: clinical effect and renal toxicity].
    Fujii M, Kiura K, Okabe K, Toki H.
    Gan To Kagaku Ryoho; 1987 Jan 15; 14(1):105-8. PubMed ID: 3099647
    [Abstract] [Full Text] [Related]

  • 15. [Treatment of non-small cell cancer of the lung with a combination of cisplatin-VP-16 and mitomycin C].
    Arraztoa J, Orlandi L, Rodríguez R, Vogel C, Ramírez G.
    Rev Med Chil; 1987 Jan 15; 115(1):31-6. PubMed ID: 3039639
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
    Colón-Otero G, Marschke R, Camoriano JK, Sorensen JM, Sloan JA, Richardson RL.
    Cancer J Sci Am; 1997 Jan 15; 3(5):297-302. PubMed ID: 9327154
    [Abstract] [Full Text] [Related]

  • 19. [Multidisciplinary treatment for small cell lung cancer].
    Saijo N, Eguchi K, Shimizu E, Shinkai T, Tominaga K, Takahashi K, Sasaki Y, Seki S.
    Gan To Kagaku Ryoho; 1984 Mar 15; 11(3):474-9. PubMed ID: 6322700
    [Abstract] [Full Text] [Related]

  • 20. Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study.
    Zatloukal P, Petruzelka L, Zemanova M, Havel L, Janku F, Judas L, Kubik A, Krepela E, Fiala P, Pecen L.
    Lung Cancer; 2004 Oct 15; 46(1):87-98. PubMed ID: 15364136
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.